WallStreetZenWallStreetZen

NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark K. OkiChief Financial Officer2025-03-1710,000$2.89
$28.89kBuy
Richard Alistair StewartChieve Executive Officer2025-03-1710,000$2.86
$28.60kBuy
John BencichCEO2024-08-165,000$3.67
$18.35kBuy
Cindy JacobsPresident CMO2024-08-162,660$3.67
$9.76kBuy
Jerry WanPrincipal Accounting Officer2024-08-162,857$3.67
$10.49kBuy

1 of 1

ACHV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dialectic Capital Management LP10.23%3,549,000$11.53MInsider
Franklin Resources Inc7.09%2,458,935$7.99MInstitution
Propel Bio Management LLC7.07%2,453,092$7.97MInstitution
Blackrock Inc5.92%2,054,014$6.68MInstitution
Robert Schacter5.27%1,827,426$5.94MInsider
Vanguard Group Inc4.95%1,717,014$5.58MInstitution
Armistice Capital LLC4.59%1,593,188$5.18MInsider
Ventures West Capital Ltd2.79%968,582$3.15MInsider
Nantahala Capital Management LLC2.59%898,885$2.92MInstitution
Geode Capital Management LLC2.22%768,966$2.50MInstitution

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV41.48%27.59%Net BuyingNet Buying
BYSI13.11%2.02%
THTX27.77%0.00%
SGMO22.54%13.81%Net SellingNet Selling
CTNM58.45%10.44%Net Buying
View Top Biotech Stocks

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 41.48% institutional shareholders, 27.59% Achieve Life Sciences insiders, and 30.92% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 10.23% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $11.53M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.